Evidence of enhanced in vivo activity using tirapazamine with paclitaxel and paraplatin regimens against the MV-522 human lung cancer xenograft

Steven Weitman, Gina Mangold, Jennifer Marty, Daniel Dexter, Susan Hilsenbeck, James Rake, Paul Juniewicz, Daniel Von Hoff

Resultado de la investigación: Articlerevisión exhaustiva

15 Citas (Scopus)

Huella

Profundice en los temas de investigación de 'Evidence of enhanced in vivo activity using tirapazamine with paclitaxel and paraplatin regimens against the MV-522 human lung cancer xenograft'. En conjunto forman una huella única.

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Psychology

Mathematics